EventsMOL2NET'23, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 9th ed.
Published
with-doi10.3390/mol2net-09-14115 (registering DOI)
This submission belongs to the session 03. NICE.XSM-09: North-Ibero-America Congress on Exp. & Simul. Methods, Valencia, Spain-Miami, USA, 2023. of the event MOL2NET'23, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 9th ed.
Published date
05 Mar, 2023
Academic Editor
author-avatarHumbert G. Díaz
Citation
Paulo SDS Pereira, Jeremias J Emídio, Igor MA De Araujo, Teresa CML Rodrigues, Nikole D Trigueiro, Jessica Moura, Alex France Messias Monteiro, Study on communic acid isomers as a potential antimicrobial against Mycobacterium tuberculosis, in Proceedings of MOL2NET'23, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 9th ed., 25 December–31 December 2023, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-09-14115
Share
Email
Facebook
Twitter
LinkedIn

Study on communic acid isomers as a potential antimicrobial against Mycobacterium tuberculosis

Paulo SDS Pereira 1
Igor MA De Araujo 1
Nikole D Trigueiro 1
Jessica Moura 1
Alex France Messias Monteiro 1
1. Postgraduate Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, Castelo Branco - João Pessoa - Brazil
Abstract

Tuberculosis is a disease that causes the most deaths in the world, it is estimated that in the last 200 years about 1 billion people died due to this infection, caused by pathogenic organisms such as Mycobacterium tuberculosis Natural products can act as a viable alternative for development of new drugs, due to their rich molecular diversity. Because of that, the objective of the following work is to bring a critical discussion about the isomers of cis-communic, trans-communic acid and their mixture in the development of an antimicrobial potential against Mycobacterium tuberculosis.

Keywords
Chemical
pharmacochemistry
chemoinformatics
Manuscript
Theoretical comparison between α, β-amyrin isomers against Staphylococcus aureus
Retinoic acid isomers as promising molecules against Alzheimer's disease